Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK has ‘turned corner’, says Garnier

October 24, 2003

News

Increased incentives for reporting prescription fraud

October 24, 2003

News

J&J strengthens biotech business

October 24, 2003
Janssen, Janssen Cilag, Johnson & Johnson, Scios

 Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.The deal, still …

News

vCJD caution prompts Serono product withdrawal

October 24, 2003

Serono is to withdraw one of its hormone products from the UK after a case of variant Creutzfeldt-Jakob disease was …

News

Iressa filed in Europe amid safety concerns

October 24, 2003

AstraZeneca has submitted its lung cancer drug Iressa for approval in Europe, despite concerns about side-effects.The novel drug was launched …

News

PowderJect splits chairman and chief executive roles

October 24, 2003

News

New trial for treatment-resistant HIV

October 24, 2003

Boehringer Ingelheim has begun a global phase III trial for a new drug it hopes will be effective for HIV …

News

Former ImClone chief fined $800,000 for insider dealing

October 24, 2003

Former ImClone boss Samuel Waksal has agreed to pay $800,000 to settle some of the charges brought against him by …

News

GSK puts new slant on Garnier pay battle

October 24, 2003

GlaxoSmithKline is to raise the issue of Chief Executive Jean-Pierre Garnier's pay once again this week, saying it is intended …

News

EU to conclude Pfizer-Pharmacia review in coming weeks

October 24, 2003

The European Commission has restarted its review of Pfizer's merger with Pharmacia, and now expects to complete the investigation of …

News

Conflict of interests halt Seroxat inquiry

October 24, 2003

If you were to ask leading CRO executives they would tell you that blue chip pharma companies outsource their critical …

News

AstraZeneca files first for European bipolar disorder

October 24, 2003

AstraZeneca have filed the first European marketing application for an atypical antipsychotic as a treatment for manic episodes related to …

News

Lilly’s well-planned campaign launches ‘spontaneity’ ED drug

October 24, 2003

Eli Lilly have launched Cialis, the first serious rival to blockbuster erectile dysfunction drug Viagra amid a flurry of media …

News

Aventis cautious as growth slows

October 24, 2003

Aventis has reined in its 2003 forecasts and warned investors that the pace of its growth would slow to a …

News

Elan shows $2.4bn loss for 2002

October 24, 2003

Irish pharmaceutical company Elan made a larger than expected loss of $2.39 billion last year.Shares in the troubled company fell …

News

Pfizer rivals face uphill struggle

October 24, 2003

Pharmaceutical companies attempting to keep up with Pfizer's industry lead have a battle on their hands, according to analysts Datamonitor.New …

News

Why can’t pharma be more like this?

October 24, 2003
Research and Development, Sales and Marketing branding, corporate

Brands are compressed bytes of information. They contain myriad messages that create impressions. If these impressions net out in a …

Feature

Industry concern over EU reform

October 24, 2003

A serious lack of progress in EU moves to reform pharmaceutical regulation is now jeopardising key objectives, according to European …

News

FDA to streamline approval process

October 24, 2003

The FDA has launched a programme to speed up approval of new drugs in response to growing concerns about lengthening …

News

GSK productivity picking up

October 24, 2003

GlaxoSmithKline's early-stage pipeline of new drugs has shown big improvements recently, according to analysts Deutsche Bank."These metrics could be taken …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026